Azurion systems with software release R1.x
FDA Recall Z-0886-2022 · Posted 2022-05-03
Advertisement
Recalling FirmPHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Recall StatusOpen, Classified
Product CodeOWB
Date Initiated2021-05-26
Product Quantity722 systems
Reason for Recall
In the Azurion system, the user can add a new study to a patient by selecting the option Add
Study . The Add Study dialogue box is then displayed where the Patient Type is selected to
perform the study. Due to a software defect, when the study is initiated by pressing Start
Procedure , the Patient Type changes inadvertently to a Patient Type different than the one
selected as shown in the Table below. Patient type is one of the factors involved in the dose
control process. The incorrect patient type changes the technique factors to be used by the
system without notification to the user.
Firm Action
Philips notified customers of the issue via Electronic Product Radiation Defect notification letter dated March 4, 2022. The letter identified the affected product, problem and actions to be taken. Customers were informed that they will be contacted by a Philips Field Service Engineers to schedule the software update at no cost. For questions contact your local Philips representative: 1-800-722-9377.
Root Cause
Software design
Distribution Pattern
US Nationwide and Worldwide Distribution
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement